跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aduscine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aduscine
Approved
STANDARD
Aduscine
Zhejiang Ruixin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ce9bad8087dd58d0
Company
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
ce9bad8087dd58d0
Drug Approval Philippines Name
Aduscine
Product Name
Aduscine
Registration Number
DRP-3350
Brand Name
Aduscine
Generic Name
Hyoscine-N-Butylbromide
Dosage Form
Solution For Injection (I.M/I.V.)
Dosage Strength
20 mg/mL
Manufacturer
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Importer
Sahar International Trading, Inc.
Distributor
Sahar International Trading, Inc.
Issuance Date
25 March 2021
Expiry Date
04 February 2026
Pharmacologic Category
Anticholinergic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ce9bad8087dd58d0
Type
Standard
Back to Philippines FDA Approvals